Study on Cervical and Endometrial Cancer in Women Aged 20 to 75

What this Trial Is About

This research aims to explore the relationship between cervical cancer and endometrial cancer with factors such as demographic information, behavior and lifestyle, pregnancy-related factors, and disease history. It also studies the factors that affect the prognosis of these cancers. Additionally, biological samples will undergo omics testing to identify diagnostic markers and prognostic biomarkers for these uterine malignancies. This is a prospective observational study with no intervention, meaning participants will not receive any specific treatment as part of the study. The study involves enrolling women diagnosed for the first time with cervical or endometrial cancer, as well as women attending health check-ups, with informed consent. Participants are observed over time to gather data relevant to cancer progression and prognosis. Participants will be involved in regular assessments and data collection related to their health and cancer status. The primary outcome measure is progression-free survival PFS monitored over 60 months. Researchers will collect and analyze biological specimens for biomarker identification. The study will continue until December 2030, with no experimental treatments administered, focusing on observation and follow-up of participants.

A Cohort Study of Uterine Malignancies